Aleš Linhart

105.1k total citations · 4 hit papers
340 papers, 8.0k citations indexed

About

Aleš Linhart is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aleš Linhart has authored 340 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Cardiology and Cardiovascular Medicine, 92 papers in Physiology and 70 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aleš Linhart's work include Lysosomal Storage Disorders Research (86 papers), Trypanosoma species research and implications (45 papers) and Cardiovascular Function and Risk Factors (43 papers). Aleš Linhart is often cited by papers focused on Lysosomal Storage Disorders Research (86 papers), Trypanosoma species research and implications (45 papers) and Cardiovascular Function and Risk Factors (43 papers). Aleš Linhart collaborates with scholars based in Czechia, United Kingdom and United States. Aleš Linhart's co-authors include Perry Elliott, Gere Sunder‐Plassmann, Jan Bělohlávek, Atul Mehta, Michael Beck, Tomáš Paleček, Vladimír Dytrych, Michael Aschermann, Jan Bultas and F. Dehout and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Aleš Linhart

311 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

2004 601 citations Aleš Linhart et al. profile →
Fabry disease revisited: Management and treatment recommendations for adult patients

2018 401 citations Alberto Ortíz, Dominique P. Germain et al. Molecular Genetics and Metabolism profile →
Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial

2022 193 citations Petr Ošťádal, Richard Rokyta et al. Circulation profile →
Cardiac Involvement in Fabry Disease

2021 177 citations Maurizio Pieroni, Eloisa Arbustini et al. profile →

Peers

Countries citing papers authored by Aleš Linhart

Since Specialization

Citations

This map shows the geographic impact of Aleš Linhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Linhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Linhart more than expected).

Fields of papers citing papers by Aleš Linhart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleš Linhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Linhart. The network helps show where Aleš Linhart may publish in the future.

Co-authorship network of co-authors of Aleš Linhart

This figure shows the co-authorship network connecting the top 25 collaborators of Aleš Linhart. A scholar is included among the top collaborators of Aleš Linhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleš Linhart. Aleš Linhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical management of female patients with Fabry disease based on expert consensus 2025 ·Orphanet Journal of Rare Diseases ·Eva Brand, Aleš Linhart, Patrick Deegan, Ruxandra Jurcuţ, Antonio Pisani, Roser Torrá, Ulla Feldt‐Rasmussen	5
2	Cardiac index, SvO2 or pCO2 gap may determine benefit from ECMO in cardiogenic shock: post-hoc analysis of the multicenter, randomized ECMO-CS trial 2025 ·Critical Care ·Petr Ošťádal, Dagmar Vondráková, Richard Rokyta, Jiří Karásek, Andreas Krüger, Marek Janotka, Jan Naar, Jana Šmalcová, (unknown), (unknown), Štefan Volovár, (unknown), Aleš Linhart, Jan Bělohlávek	0
3	Anderson–Fabry Disease Homozygosity: Rare Case of Late-Onset Variant 2024 ·SHILAP Revista de lepidopterología ·Gabriela Dostálová, Jaroslav Januška, (unknown), (unknown), (unknown), (unknown), David Zemánek, Aleš Linhart	1
4	The results of a survey: "Diagnosis and treatment of heart failure in the clinical practice" 2024 ·Vnitřní lékařství ·Filip Málek, Aleš Linhart, Radek Pudil, (unknown)	0
5	Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: 1-Year Outcomes of the Multicentre, Randomized ECMO-CS Trial 2024 ·European Journal of Heart Failure ·Petr Ošťádal, Richard Rokyta, Jiří Karásek, Andreas Krüger, Dagmar Vondráková, Marek Janotka, Jan Naar, Jana Šmalcová, (unknown), Milan Hromádka, Štefan Volovár, (unknown), Aleš Linhart, Jan Bělohlávek, (unknown)	3
6	Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies 2023 ·Circulation Genomic and Precision Medicine ·Emanuele Monda, (unknown), Francesca Graziani, Marta Rubino, Athanasios Bakalakos, Aleš Linhart, Dominique P. Germain, Maurizio Scarpa, Elena Biagini, Maurizio Pieroni, Perry Elliott, Giuseppe Limongelli	8
7	Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study 2023 ·EP Europace ·Štěpán Havránek, (unknown), Tomáš Skála, (unknown), (unknown), Pavel Jansa, David Ambrož, Vladimír Dytrych, (unknown), Martin Hutyra, Josef Kautzner, Aleš Linhart, Dan Wichterle	5
8	Restrictive cardiomyopathy: definition and diagnosis 2022 ·European Heart Journal ·Claudio Rapezzi, Alberto Aimo, Andrea Barison, Michele Emdin, Aldostefano Porcari, Aleš Linhart, Andre Keren, Marco Merlo, Gianfranco Sinagra	90
9	Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension 2022 ·Journal of Clinical Medicine ·Pavel Jansa, David Ambrož, Michael Aschermann, Vladimír Černý, Vladimír Dytrych, (unknown), Jan Kunstýř, Jaroslav Lindner, Aleš Linhart, (unknown), Michal Paďour, (unknown), Michal Širanec, Susan Edwards, Virginie Gressin, (unknown), Lilla Di Scala	1
10	Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial breakdown → 2022 ·Circulation ·Petr Ošťádal, Richard Rokyta, Jiří Karásek, Andreas Krüger, Dagmar Vondráková, Marek Janotka, Jan Naar, Jana Šmalcová, (unknown), (unknown), Štefan Volovár, (unknown), Jiří Jarkovský, Michal Svoboda, Aleš Linhart, Jan Bělohlávek, (unknown)	193
11	Systematic COronary Risk Evaluation (SCORE) and 20-year risk of cardiovascular mortality and cancer 2020 ·European Journal of Internal Medicine ·Peter Wohlfahrt, Jan Bruthans, Alena Krajčoviechová, Pavel Šulc, Aleš Linhart, Jan Filipovský, Otto Mayer, J Widimský, M. Bláha, Jitka Abrahámová, Renata Cífková	8
12	Predictors of survival in patients with pulmonary hypertension and acute right heart failure 2020 ·Bratislavské lekárske listy/Bratislava medical journal ·David Ambrož, Pavel Jansa, (unknown), Jan Bělohlávek, Michael Aschermann, Vladimír Dytrych, Jaroslav Lindner, Iveta Šimková, Aleš Linhart	7
13	Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry 2020 ·European Heart Journal - Quality of Care and Clinical Outcomes ·Juan R. Gimeno, Perry Elliott, Luigi Tavazzi, Michał Tendera, Juan Pablo Kaski, Cécile Laroche, Roberto Barriales‐Villa, Petar Seferović, Elena Biagini, Eloisa Arbustini, Luís R. Lopes, Aleš Linhart, Jens Mogensen, Albert Hagège, María Ángeles Espinosa, Aly M A Saad, Aldo P. Maggioni, Alida L.P. Caforio, Philippe Charron, (unknown)	5
14	Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 2018 ·Molecular Genetics & Genomic Medicine ·Dominique P. Germain, Eva Brand, Alessandro P. Burlina, Franco Cecchi, Scott C. Garman, Judy Kempf, Dawn A. Laney, Aleš Linhart, László Maródi, Kathy Nicholls, Alberto Ortíz, Federico Pieruzzi, Suma P. Shankar, Stephen Waldek, Christoph Wanner, Ana Jovanović	81
15	Fabry disease revisited: Management and treatment recommendations for adult patients breakdown → 2018 ·Molecular Genetics and Metabolism ·Alberto Ortíz, Dominique P. Germain, Robert J. Desnick, Juan Politei, Michael Mauer, Alessandro P. Burlina, Christine M. Eng, Robert J. Hopkin, Dawn A. Laney, Aleš Linhart, Stephen Waldek, Eric Wallace, Frank Weidemann, William R. Wilcox	401
16	A rare case of regressively changed lipomatous hypertrophy of the interatrial septum presenting with anemia and recurrent fever 2015 ·Cardiovascular Pathology ·Daniel Rob, Petr Kuchynka, Tomáš Paleček, Vladimír Černý, Martin Mašek, Ivana Vítková, (unknown), (unknown), David Zogala, Aleš Linhart	0
17	[Myocardial infarction, left ventricle remodeling and cellular therapy]. 2009 ·PubMed ·Hana Skalická, J Horák, Michael Aschermann, Aleš Linhart, Tomáš Paleček, (unknown)	1
18	Analysis of costs of treatment of patients with atrial fibrillation in the Czech Republic 2008 ·Cor et Vasa ·(unknown), Martin Fiala, Jan Chovančík, Dan Wichterle, Robert Čihák, Marian Branny, Aleš Linhart, (unknown), Josef Kautzner	2
19	[Takotsubo cardiomyopathy: case report and literature review]. 2005 ·PubMed ·Tomáš Paleček, Aleš Linhart, Pavel Jansa, Jean-Claude Lubanda, Jan Bělohlávek, (unknown), (unknown), Michael Aschermann	3
20	Tobacco use amongst high school students in the Czech Republic. 2004 ·PubMed ·(unknown), Jean-Claude Lubanda, (unknown), Lenka Bošanská, (unknown), Aleš Linhart, (unknown), (unknown), Michael Aschermann	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact